云南白药增资至17.8亿元

Group 1 - Yunnan Baiyao has undergone significant management changes, with Dong Ming stepping down as the legal representative and Wang Minghui resigning as chairman, replaced by Zhang Wenxue [1][2] - The registered capital of Yunnan Baiyao has increased from approximately 1.04 billion RMB to about 1.78 billion RMB [1][2] - The company was established in November 1993 and operates in various sectors including chemical raw materials, traditional Chinese medicine, and medical devices [1][3] Group 2 - The company is jointly held by Yunnan Provincial State-owned Assets Management Company, Xinhua Duhua Industrial Group Co., Ltd., and Yunnan Hehe Group Co., Ltd. [1][4] - The 11th Board of Directors meeting announced Zhang Wenxue as chairman and Dong Ming as vice chairman for a term of three years [1][2] - The company has a diverse business scope that includes sales of pharmaceuticals, medical devices, and technology consulting services [1][3]